These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15253741)

  • 1. Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients.
    Anraku M; Kitamura K; Shinohara A; Adachi M; Suenga A; Maruyama T; Miyanaka K; Miyoshi T; Shiraishi N; Nonoguchi H; Otagiri M; Tomita K
    Kidney Int; 2004 Aug; 66(2):841-8. PubMed ID: 15253741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study.
    Anraku M; Kitamura K; Shintomo R; Takeuchi K; Ikeda H; Nagano J; Ko T; Mera K; Tomita K; Otagiri M
    Clin Biochem; 2008 Oct; 41(14-15):1168-74. PubMed ID: 18692036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation.
    Tovbin D; Mazor D; Vorobiov M; Chaimovitz C; Meyerstein N
    Am J Kidney Dis; 2002 Nov; 40(5):1005-12. PubMed ID: 12407646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of serum albumin level on iron-induced oxidative stress in chronic renal failure patients.
    Sezer MT; Akin H; Demir M; Erturk J; Aydin ZD; Savik E; Tunc N
    J Nephrol; 2007; 20(2):196-203. PubMed ID: 17514624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
    Terawaki H; Nakayama K; Matsuyama Y; Nakayama M; Sato T; Hosoya T; Era S; Ito S
    Blood Purif; 2007; 25(3):274-9. PubMed ID: 17460395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
    Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure.
    Himmelfarb J; McMonagle E; McMenamin E
    Kidney Int; 2000 Dec; 58(6):2571-8. PubMed ID: 11115093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin is the major plasma protein target of oxidant stress in uremia.
    Himmelfarb J; McMonagle E
    Kidney Int; 2001 Jul; 60(1):358-63. PubMed ID: 11422772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients.
    Mera K; Anraku M; Kitamura K; Nakajou K; Maruyama T; Tomita K; Otagiri M
    Hypertens Res; 2005 Dec; 28(12):973-80. PubMed ID: 16671336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of olmesartan on oxidative stress in hemodialysis patients.
    Kadowaki D; Anraku M; Tasaki Y; Kitamura K; Wakamatsu S; Tomita K; Gebicki JM; Maruyama T; Otagiri M
    Hypertens Res; 2007 May; 30(5):395-402. PubMed ID: 17587751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst.
    Mera K; Anraku M; Kitamura K; Nakajou K; Maruyama T; Otagiri M
    Biochem Biophys Res Commun; 2005 Sep; 334(4):1322-8. PubMed ID: 16054887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype.
    Armaly Z; Abd El Qader A; Jabbour A; Hassan K; Ramadan R; Bowirrat A; Bisharat B
    BMC Nephrol; 2015 Aug; 16():135. PubMed ID: 26268514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemia modified albumin and carbonyl protein as potential biomarkers of protein oxidation in hemodialysis.
    Albarello K; dos Santos GA; Bochi GV; Sangoi MB; Almeida TC; Paz da Silva JE; Garcia SC; Moresco RN
    Clin Biochem; 2012 Apr; 45(6):450-4. PubMed ID: 22342921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a hydrogen (H2)-enriched solution on the albumin redox of hemodialysis patients.
    Terawaki H; Zhu WJ; Matsuyama Y; Terada T; Takahashi Y; Sakurai K; Kabayama S; Miyazaki M; Itami N; Nakazawa R; Ito S; Era S; Nakayama M
    Hemodial Int; 2014 Apr; 18(2):459-66. PubMed ID: 24274030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.
    Tarng DC; Huang TP; Wei YH; Liu TY; Chen HW; Wen Chen T; Yang WC
    Am J Kidney Dis; 2000 Nov; 36(5):934-44. PubMed ID: 11054349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin.
    Terawaki H; Yoshimura K; Hasegawa T; Matsuyama Y; Negawa T; Yamada K; Matsushima M; Nakayama M; Hosoya T; Era S
    Kidney Int; 2004 Nov; 66(5):1988-93. PubMed ID: 15496170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of redox state of human serum albumin before and after hemodialysis.
    Soejima A; Matsuzawa N; Hayashi T; Kimura R; Ootsuka T; Fukuoka K; Yamada A; Nagasawa T; Era S
    Blood Purif; 2004; 22(6):525-9. PubMed ID: 15583477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress in renal anemia of hemodialysis patients is mitigated by epoetin treatment.
    Siems W; Carluccio F; Radenkovic S; Grune T; Hampl H
    Kidney Blood Press Res; 2005; 28(5-6):295-301. PubMed ID: 16534224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.